The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / U.S. Food and Drug Administration (FDA)

Articles tagged with "U.S. Food and Drug Administration (FDA)"

FDA Approves New Rituximab Biosimilar & Anakinra to Treat a Rare Disease

February 2, 2021 • By Michele B. Kaufman, PharmD, BCGP

FDA Provides 2020 Rheumatology Drug Update

December 17, 2020 • By Susan Bernstein

Emergency Use Approved for Baricitinib with Remdesivir Combination Therapy for SARS-CoV-2

December 3, 2020 • By Michele B. Kaufman, PharmD, BCGP

FDA Warning: Avoid Use of NSAIDs after Week 20 of Pregnancy

October 28, 2020 • By Michele B. Kaufman, PharmD, BCGP

FDA Approves Golimumab for Patients with pJIA & Psoriatic Arthritis

October 21, 2020 • By Michele B. Kaufman, PharmD, BCGP

FDA Approves Tofacitinib for Young Patients with Active Polyarticular JIA

October 9, 2020 • By Michele B. Kaufman, PharmD, BCGP

FDA Updates Boxed Warning of Benzodiazepines, Adding Risks for Abuse & Addiction

October 7, 2020 • By Michele B. Kaufman, PharmD, BCGP

FDA Receives Upadacitinib Application for Ankylosing Spondylitis & Approves Tramadol Hydrochloride Oral Solution

September 30, 2020 • By Michele B. Kaufman, PharmD, BCGP

U.S. & E.U. Differ on Filgotinib for RA

September 14, 2020 • By Michele B. Kaufman, PharmD, BCGP

ACR Leaders Discuss Hydroxychloroquine Issues with FDA Commissioner

August 10, 2020 • By From the College

  • 1
  • 2
  • 3
  • …
  • 10
  • Next Page »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

This site uses cookies: Find out more.